Sympatholytic drugs Flashcards

1
Q

Sympatholytic drugs used hypertension

A

α-adrenoceptor antagonists
β-adrenoceptor antagonists
Centrally acting α2-adrenoceptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

α-adrenoceptor antagonists - cardiovascular effects

A

PVR: Decrease
Activate RAA
Left ventricular hypertrophy: Decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

β-adrenoceptor antagonists - cardiovascular effects

A

Cardiac output: decrease
Plasma renin activity: decrease
Left ventricular hypertrophy: decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Centrally acting α2-adrenoceptor agonists - cardiovascular effects

A

PVR: Decrease
Blood volume: increase (except guanfacine)
Plasma renin activity: decrease
Left ventricular hypertrophy: decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

α-adrenoceptor antagonists - effect on potassium and cholesterol

A

Total cholesterol: Decrease
LDLs: Decrease
HDLs: Increase
TGs: Decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

α-adrenoceptor antagonists - adverse effects

A

Dizziness, first-dose syncope, fluid retention, orthostatic hypotension.
Selective α1-blockers: Reflex activation of sympathetic nervous system (increased HR, contractile force, NE levels, oxygen demand).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

β-adrenoceptor antagonists - adverse effects

A

Bradycardia, bronchoconstriction, depression, fatigue, impaired glycogenolysis, vivid dreams, orthostatic hypotension, hepatic, renal and hematopoietic toxicity. Reduced exercise capacity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

α- and β-adrenoceptor antagonists - interactions

A

β-adrenoceptor antagonists: Cardiac depression is increased by diltiazem and verapamil. Hypotensive effect decreased by NSAIDs.
α-adrenoceptor antagonists: Hypotensive effect is increased by β-adrenoceptor antagonists and diuretics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Selective α1-blockers - indications and contraindication in hypertension

A

NOT initial treatment. Added to other drugs if not properly cotrolled.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Selective α1-blockers used for HT

A

Doxazosin
Prazosin
Terazosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

β-blockers - MOA and indications HT

A

MOA: Decrease HR and contractility, inhibit renin secretion.
Indications: HT with cardiovascular diseases (e.g. coronary heart disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Carvedilol - indications in HT and reason for this indication

A

Diabetes - may improve insulin sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selective β1-blockers used in HT

A

Atenolol, bisoprolol, metoprolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Atenolol - advantages

A

Fewer nervous system side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Labetalol - indications and adverse effects

A

Indications: Chronic hypertension, hypertensive emergencies

Adverse effects: Orthostatic hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Esmolol - indication - adm - reason for indication

A

Adm IV. HT in surgery and hypertensive emergencies. Is a ultrashort-acting β1-blocker.

17
Q

Third-generation α and β-blockers

A

Carvedilol.

Nebivolol.

18
Q

Nebivolol - indications

A

HT in heart failure, diabetes, cardiac arrhythmias.

19
Q

Nebivolol - effects

A

Selective β1-blocker.
Antioxidant properties.
Increases NO from endothelial cells.

20
Q

Centrally acting sympatholytics

A

Clonidine
Guanfacine
Methyldopa

21
Q

Clonidine, guanfacine, methyldopa - adverse effects

A

Dry mouth, fatigue, rebound hypertension, sedation, decreased mental acuity. These adverse effects are milder in guanfacine than clonidine.
Methyldopa: Autoimmune hemolytic anemia, hepatitis, lupus-like syndrome.

22
Q

Clonidine, guanfacine, methyldopa - interactions

A

Tricyclic antidepressants - decrease hypotensive effect.
CNS depressants - increased sedative effect.
Methyldopa: Levodopa cause increased hypotensive effect.

23
Q

Centrally acting sympatholytics - MOA

A

Reduce sympathetic outflow by activation of central α2-adrenoceptors in medulla. This reduces vascular resistance, little effect on HR and cardiac output.

24
Q

Centrally acting sympetholytics - contra and why

A

Abrupt discontinuation - severe rebound hypertension.
Tricyclic antidepressants - block effect of these sympatholytics.
Clonidine - Not used for chronic treatment because of more side effects.

25
Q

Clonidine and methyldopa- indications

A

Hypertensive emergencies. Symptoms of alcohol, opioid or nicotine withdrawal.
Methyldopa: HT in pregnancy